Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia

Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia

OBJECTIVES:. To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia. DESIGN:. Cohort study. SETTING:. Thirteen hospitals in New Jersey, United States during March to June 2020...

Full description

Bibliographic Details
Main Authors: Ronaldo C. Go, MD, Roshan Shah, MD, Themba Nyirenda, PHD, Yukiko Oe, MD, Khurram Sarfraz, MD, Justin J. Panthappattu, MD, Lesley Philip, MD, Chandni Bheeman, DO, Neel Shah, DO, Sapan Shah, MD, Sophia Dar, MD, Sung Hung, MD, Waqas Rahman, MD, Hyun Im, MD, Michael Marafelias, Karan Omidvari, MD, Anuja Pradhan, MD, Sean Sadikot, MD, Keith M. Rose, MD, Steven J. Sperber, MD, Joshua Josephs, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-07-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000493

Internet

http://journals.lww.com/10.1097/CCE.0000000000000493

Similar Items